Table 3. Grades 3 and 4 AEs of patients with advanced NSCLC.
| AEs | Placebo (n=46) | Nab-paclitaxel (n=46) | ||
|---|---|---|---|---|
| Number | % | Number | % | |
| Total | 4 | 6.5 | 16 | 34.8 |
| Rash | 0 | 0 | 4 | 8.7 |
| Nausea | 1 | 2.2 | 3 | 6.5 |
| Vomiting | 0 | 0 | 2 | 4.3 |
| Stomatitis | 0 | 0 | 2 | 4.3 |
| Pruritus | 0 | 0 | 0 | 0 |
| Anorexia | 0 | 0 | 3 | 6.5 |
| Diarrhoea | 2 | 4.3 | 6 | 13.0 |
| Paronychia | 0 | 0 | 3 | 6.5 |
| Fatigue | 1 | 2.2 | 6 | 13.0 |
| Infection | 0 | 0 | 5 | 10.9 |
| Thrombocytopaenia | 1 | 2.2 | 4 | 8.7 |
| Pulmonary fibrosis | 0 | 0 | 2 | 4.3 |
| Leucopenia | 2 | 4.3 | 5 | 10.9 |